Mymetics Corp (MYMX) financial statements (2021 and earlier)

Company profile

Business Address EUROPEAN EXECUTIVE OFFICE
EPALINGES, CH-1066
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1101122
Cash and cash equivalents1101122
Receivables001000 
Prepaid expense0000000
Other undisclosed current assets      0
Total current assets:1111232
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment0000000
Intangible assets, net (including goodwill)7777799
Goodwill7777777
Intangible assets, net (excluding goodwill)     22
Deposits noncurrent assets0      
Total noncurrent assets:7777799
TOTAL ASSETS:888881211
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities0000001
Accounts payable0000001
Debt5653     
Due to related parties75     
Other undisclosed current liabilities0   474440
Total current liabilities:635900474541
Noncurrent Liabilities
Long-term debt and lease obligation00     
Long-term debt, excluding current maturities0      
Operating lease, liability00
Other undisclosed noncurrent liabilities(0)      
Total noncurrent liabilities:00     
Other undisclosed liabilities  5551   
Total liabilities:63595551474541
Stockholders' equity
Stockholders' equity attributable to parent(55)(51)(47)(43)(39)(33)(30)
Common stock3333333
Additional paid in capital34343434343434
Accumulated other comprehensive income1111111
Accumulated deficit(93)(89)(85)(81)(76)(70)(67)
Total stockholders' equity:(55)(51)(47)(43)(39)(33)(30)
TOTAL LIABILITIES AND EQUITY:888881211

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1112132
Revenue, net1110
Other income111   
Cost of revenue(0)(0)(0) (2) (0)
Gross profit:1112(1)32
Operating expenses(2)(2)(2)(3)(2)(4)(3)
Other operating expense, net
(Other Expenses)
 (0)     
Other undisclosed operating income 0 0 0 
Operating loss:(2)(1)(2)(2)(3)(0)(1)
Nonoperating expense
(Other Nonoperating expense)
(0)      
Interest and debt expense(3)(3)(3)(3)(3)(3)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes9      
Income (loss) from continuing operations before equity method investments, income taxes:4(4)(4)(4)(6)(3)(3)
Other undisclosed income (loss) from continuing operations before income taxes(8)   0  
Loss from continuing operations before income taxes:(4)(4)(4)(4)(6)(3)(3)
Income tax expense (benefit)(0)(0)(0)(0)0(0)0
Net loss available to common stockholders, diluted:(4)(4)(4)(4)(6)(3)(3)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(4)(4)(4)(4)(6)(3)(3)
Comprehensive loss:(4)(4)(4)(4)(6)(3)(3)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent000(0) 0(0)
Comprehensive loss, net of tax, attributable to parent:(4)(4)(4)(4)(6)(3)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: